Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Author, Hepatitis C Advocate, Health Educator
Hepatitis C virus infection is on the rise among women giving birth, putting a new generation at risk for infection.
Hepatitis C is curable, but it is not gone. Not by a long shot.
The facts about hepatitis C are offset by ignorance. This diver is trying to set the facts straight.
Liver cancer risk is higher if you have cirrhosis or late stage fibrosis, alcohol use, hepatitis B, and fatty liver disease.
When dealing with hepatitis C, our attitude can be an ally or an enemy.
Although the newest hepatitis C treatments are wonderful, they don’t fix everything. Are you at risk?
Highlights from the 2017 Liver Meeting, presented by the American Association for the Study of Liver Diseases.
Headlines from the 2017 Liver Meeting
Updated information about the most common liver disease in the United States, nonalcoholic fatty liver disease (NAFLD).
A look at the latest hepatitis C guidelines
The public is invited to comment on the U.S. Preventive Services Task Force draft plan on screening for hepatitis C in teens and adults.
The Graham-Cassidy Bill threatens health care. Your daughter who has diabetes, your brother with heart disease may be denied insurance.
In other than hurricane news, at least 16 people are dead as a result of the hepatitis A outbreak in San Diego.
Sharing paraphernalia used to cook and prepare injection drugs does not directly lead to transmission of hepatitis C virus.
Hepatic encephalopathy (HE) is a brain disorder that develops when the liver is cirrhotic and unable to remove toxins in the body.
Hepatitis B reactivation is an infrequent but not rare complication of hepatitis C treatment in hepatitis B and C-coinfected patients.
Vaccines can prevent hepatitis A and hepatitis B, and information about National Immunization Awareness Month
A large study shows that hepatitis C treatment is associated with increased mortality.
The Food and Drug Administration (FDA) recently approved AbbVie’s Mavyret, the newest treatment for chronic hepatitis C.
A look at Vosevi, the newest treatment for chronic hepatitis C virus infection for people without cirrhosis or with compensated cirrhosis
A look at two topics in this week’s news - the newest approved hepatitis C drug (Vosevi) and World Hepatitis Day.
Hepatitis C and supplements might not be a good mix, as supplements can injure the liver.
Most of us don’t expect to acquire hepatitis C after a trip to the hospital or lab, but it happens. You can reduce your risk of this.
Key points about the latest CDC hepatitis surveillance data.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.